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http:WHAT THIS PAPER ADDS
Attempts have been made to reduce the cost of ultrasound equipment, operators, and their training, which make
up a signiﬁcant proportion of the cost of abdominal aortic aneurysm (AAA) screening programmes. With this in
mind, the BVI 9600 promised to be a cost-effective automated ultrasound device to detect AAA without a trained
operator. Prior reports are equivocal about its suitability, and this study evaluates the accuracy of this device for the
purpose of detecting AAA as part of a low-cost AAA screening programme.We describe some critical limitations of
this device and recommend improvements required before it or other similar devices could be used in screening.Objectives: Despite a decreasing incidence of abdominal aortic aneurysm (AAA), the cost-effectiveness of AAA
ultrasound screening can be improved by reducing the screening costs and increasing the uptake rates. The BVI
9600 (BVI) is a promising tool for this purpose as it is inexpensive and can detect AAA without a trained operator.
This study aims to investigate whether the BVI can be used to detect AAA for the purpose of a low-cost outreach
screening approach.
Methods: A total of 142 subjects had their abdominal aortae measured by ﬁve sonographers using the BVI and a
conventional ultrasound machine. The examination included four anterioreposterior measurements at four
equally spaced scanning locations from the xiphisternum to the umbilicus. The measurements produced by each
machine were compared using BlandeAltman plots, followed by an analysis of the AAA detection performance.
Results: The BVI measured the aortic diameter to within 0.88e1.56 cm of the true diameter, exceeding the
0.5 cm “clinically acceptable difference” (CAD). Its accuracy was poorer when measuring the aneurysmal aortae
(mean difference 0.56 cm, variability 1.72 cm) than normal aortae (mean difference 0.02 cm, variability
0.76 cm). Nine out of 52 aneurysms were not detected due to undersizing measurement and non-visualization of
the aortae.
Conclusions: At present, the BVI is not sufﬁciently accurate to detect AAA for screening purposes. A number of
technical features require improvement.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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National screening programmes for abdominal aortic
aneurysm (AAA) are being implemented based on the re-
sults from several randomized trials in the 1990s.1 These
trials suggested that AAA prevalence and the expected
number of AAA detected by ultrasound screening were
sufﬁciently high to justify the beneﬁts and cost-
effectiveness of screening. Although the beneﬁts of AAA
screening remain signiﬁcant,2 the cost-effectiveness of
screening in the future is uncertain. Such uncertaintyrresponding author. A.M. van Rij, Department of Surgical Sciences,
in School of Medicine, University of Otago, PO Box 56, Dunedin
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//dx.doi.org/10.1016/j.ejvs.2014.04.030emerged after the observation that incidence of AAA is
decreasing3 and current screening programmes have low
yield.4,5 Lederle6 suggested that such low yield could be due
to low uptake rates by populations with high risk of AAA,
many of whom are socially deprived and living in rural
areas.7 In addition, the current screening approach is ex-
pected to be costly in the long term due to expensive ul-
trasound equipment8 and the ongoing training costs of
screeners with high turnover rates.9 In order to maintain
the cost-effectiveness of screening in the future, it is
necessary to have a different screening model that costs
less and produces a higher uptake. With this in mind, the
BVI 9600 (Verathon Medical UK Ltd, High Wycombe, UK)
has been trialled for AAA screening with some promising
results.10 This device is inexpensive and can be used by
operators without training in ultrasound imaging. Therefore,
screening can potentially be provided at low cost by
Figure 1. The four scanning locations of the BVI (A, B, C, and D) at
which the anterioreposterior aortic diameters were measured in
the transverse plane.
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geographical location, thus potentially increasing the uptake
rate of rural dwellers.
In addition to being cost-effective, a successful screening
programme needs to be safe. This relies on the accuracy of
the ultrasound device at measuring the aortic diameter. Two
previous studies in this topic provided conﬂicting results;
Flu et al.10 concluded that the device demonstrated
acceptable sensitivity whereas Abbas et al.11 suggested that
the device lacks adequate sensitivity for screening. Our aim
was to investigate further whether the BVI 9600 (BVI) is
sufﬁciently accurate and with sufﬁciently low variability to
be used in AAA screening. The BVI was compared with a
conventional ultrasound (US) machine for accuracy of aortic
measurements and AAA detection performance.
METHODS
Settings and patient recruitment
This study was conducted over a 4-month period, with par-
ticipants recruited from patients referred to the Otago
Vascular Diagnostics Laboratory in Dunedin. Inclusion criteria
was people aged 50 years and above.Therewere no exclusion
criteria other than age <50 years. Some participants had
existing known AAA and were either under surveillance or
awaiting treatment.Written, informed consent was obtained
having ethical approval from the regional Ethics Committee.
Equipment
The BVI has a 3.0-MHz circular transducer of 18 cm pene-
tration depth capacity. It generates a three-dimensional (3D)
scan of the aortic region using ultrasound reﬂections on
multiple planes in order to construct a 3D geometry of the
aorta. Subsequently, the diameter of the aorta is directly
deduced.10 If the diameter is deemed 3.0 cm or larger, its
speciﬁc measurement is shown with a “result display” (which
shows a B-mode cross-sectional image of aorta) and an
“aiming display” (which shows the position of the aorta
relative to the US probe). If the diameter is deemed to be less
than 3.0 cm, the measurement and “aiming display” will not
be shown, in which case the operatormanuallymeasured the
diameter on the “result display” using electronic callipers.
Comparison US evaluation of the aortic diameters was per-
formed by a conventional US device (Toshiba Alipo XG,
Zoetmeer, The Netherlands) with a 3.5-MHz abdominal
transducer of 28 cm penetration depth capacity, used
routinely in the clinical setting.
Operators
The operators were ﬁve experienced vascular sonographers.
A training session was provided by the device manufacturer,
including an instruction booklet for revision. None of the
operators had used this device prior to this study.
Scanning process
Each aorta was measured by one sonographer using the BVI
ﬁrst, followed by a second blinded sonographer using theconventional US machine. Four anterioreposterior aortic
diameter measurements were taken on the transverse
plane at four equally spaced segments marked along the
midline between the xiphisternum and the umbilicus as per
the manufacturer’s instructions (Fig. 1). Measurements us-
ing the BVI and conventional US were made at the same
marked points. The aortic diameter was measured from
inner-to-inner (ITI) sides of the wall using the BVI, whereas
using conventional US the aortae were measured from the
outer-to-outer (OTO) sides of the walls as in the clinical
setting. We deﬁned an AAA as one with a diameter of
3.0 cm or more at any aortic segment, measured from the
OTO of the aortic walls. Patients found to have a previously
undiagnosed AAA by the conventional US machine were
referred back for formal evaluation in the vascular
laboratory.Statistical analysis
The repeated measurements from both machines were
compared. The variability, calculated as 1.96 times the
standard deviation of the mean difference, signiﬁes how
much the BVI measurements varied from those of the
conventional US system. This variability was compared with
a clinically acceptable difference (CAD) of 0.5 cm, described
by Jaakola et al.12 The 95% limits of agreement (LOA),
calculated by the sum of the mean difference and the
variability, is the range within which 95% of the differences
between the BVI and the US measurements lie. The above
statistical measures are illustrated using BlandeAltman
plots in which the differences between measurements of
each BVIeUS pair are plotted against the averages of those
Figure 2. BlandeAltman plots illustrating the BVI measurement
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the BVI measurements that were within 0.5 cm of the US
measurements, was calculated as described by Lederle
et al.13 Kappa statistics were calculated to determine the
inter-observer agreement of the AAA detection between
the BVI and US. An analysis of the sensitivity, speciﬁcity,
positive predictive value (PPV), and negative predictive
value (NPV) was performed to enable a direct comparison
with the literature. However, the conclusion of our data was
drawn from the measurement of variability and the Blande
Altman plots for comparing two clinical methods.14 Visual-
isation proportion was deﬁned as the proportion of aortic
segments that were visualised adequately to enable aortic
diameter measurements by each device. An analysis of the
aneurysms that the BVI failed to detect was performed with
regard to the likely accountable factors. These statistical
analyses were applied to measurements of individual seg-
ments of the aorta (A, B, C, and D) and the maximal aortic
diameter (the largest measurement out of these four
measurements).bias where aortic diameters were consistently under-measured,
with increasing variability as aortic diameter increased. The
dotted red lines demarcate the limits of agreement (mean
difference  1.96  SD), the horizontal line is drawn at the mean
difference and the variability is indicated as the distance between
the horizontal line and each of the dotted red line.RESULTS
During the study period, 142 participants were scanned. The
mean maximal aortic diameter of all the aortae was 3.02 cm
(range 1.39e9.46 cm); that of normal aortae was 2.11 cm
and of aneurysmal aortae 4.63 cm. Conventional US
detected 52 aneurysms (size 3.10e9.46 cm); the BVI
detected 43 aneurysms (83%), including eight of the 12
large aneurysms (>5.5 cm, 67%) and 35 of the 40 small and
medium aneurysms (3.0e5.4 cm, 88%).Inter-device differences
The measurement mean differences, variability, and LOA for
the BVIeUS pairs of each aortic segment are presented in
Table 1. The BVI measurements were within the CAD in 75e
87% of the time. However, overall the variability was large,
ranging between 0.88 and 1.56 cm (Table 1), and increased
as aortic diameter increased (Fig. 2). Measurements at the
distal segments (C and D) were less accurate than those of
the proximal segments (A and B), though a systemic mea-
surement bias was present with the BVI consistently under-
measuring aortic diameters (Fig. 2). The distal aortic seg-
ments were found to associate with more aortic dilatationsTable 1. BVI compared with conventional ultrasound: mean diffe
measurements within the clinically acceptable difference (CAD), and t
aorta taken in the transverse plane at location A, B, C, and D and the
Mean difference (95% CI) Variability LOA Pro
wit
A 0.02 (0.11 to 0.07) 0.88 0.90, 0.86 77
B 0.03 (0.12 to 0.06) 0.94 0.97, 0.91 81
C 0.12 (0.25 to 0.02) 1.48 1.59, 1.36 80
D 0.27 (0.41 to 0.13) 1.56 1.83, 1.29 77
Maximum 0.19 (0.31 to 0.08) 1.32 1.48, 1.10 78
a Number of BVIeUS pairs. Scans from which no measurement could b
of BVIeUS pairs are different at each aortic segment. CAD: differenceover 3.0 cm than the proximal counterparts (32 and 42
aneurysms at C and D respectively, compared to 3 and 10 at
A and B).Measurement accuracy of the aneurysmal aortae and non-
aneurysmal aortae
The measurement accuracy of the BVI when measuring
aneurysmal aortae was distinctly inferior to that of normal
aortae (Fig. 2). This was also demonstrated by a lower
percentage of measurements that achieved the CAD (59%
vs. 88%, p < .05), a larger systematic bias (mean
difference 0.56 vs. 0.02 cm) and a larger variability
(1.72 cm vs. 0.76 cm) (Table 2). Consequently, the BVI failed
to detect three aneurysms (3.1 cm, 3.56 cm, and 5.74 cm)
due to an under-measurement by 0.9e3.9 cm compared to
conventional US equipment.rences, variabilities, limits of agreement (LOA), proportion of
he number of missed images for measurements of the abdominal
maximal measurement from 142 subjects.
portion
hin CAD (%)
na
(total ¼ 142)
Total number
of missed
images
Number of
non-visualised
segments (BVI, US)
101 41 (29%) 35 (25%), 19 (13%)
112 30 (21%) 25 (18%), 8 (6%)
120 22 (15%) 21 (15%), 3 (2%)
123 19 (13%) 18 (13%), 5 (4%)
135 7 (5%) 7 (5%), 0
e obtained were excluded from the analysis and thus the numbers
<0.5 cm.
Table 2. BVI compared with conventional ultrasound: mean differences, variabilities and limits of agreement (LOA), proportion of
measurements within the clinically acceptable difference (CAD), and the number of missed images of the maximum normal and
aneurysmal aortae diameters with BVI.
Mean difference (95% CI) Variability LOA Proportion within
CAD (%)
na Number of non-visualised
segments (BVI)
Normal aortae 0.02 (0.06 to 0.10) 0.76 0.73, 0.76 88 86 4 (4.4%)
Aneurysmal aortae 0.56 (0.81 to 0.32) 1.72 2.25, 1.11 59 49 3 (5.8%)
a Number of BVIeUS pairs. Scans from which no measurement could be obtained were excluded from the analysis. CAD: difference
<0.5 cm.
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Non-visualisation occurred more frequently among aortic
scans by the BVI (18% of all scan measurements) than the
conventional US system (6%) (Table 1). Complete non-
visualisation (i.e., involving all four aortic segments)
occurred in seven aortae examined by the BVI; whereas this
issue was not encountered by the conventional US. Simi-
larly, non-visualisation of the distal segments (C or D)
occurred in 19 aortae examined by the BVI, compared to
eight by conventional US. Consequently, the BVI failed to
detect three aneurysms (size 3.7, 5.47, and 6.17 cm) due to
complete non-visualisation and another three aneurysms
(size 3.4, 4.0, and 5.6 cm) due to non-visualisation of the
distal segments.
Aneurysm detection
The BVI had modest levels of agreement with US in the
diagnosis of AAA, having a kappa coefﬁcient of 0.83 (95% CI
0.73e0.92). The sensitivity was 83% (70e92%), speciﬁcity
98% (92e100%), positive predictive value 96% (85e99%),
negative predictive value 90% (82e96%), false positive rate
2% and false negative rate 17%.
DISCUSSION
The BVI is a promising tool, suitable for a low-cost and easily
accessible AAA screening outreach approach. Unfortunately,
its accuracy in AAA detection has not received much
attention from the screening literature. This study evaluated
the measurement accuracy of the BVI against that of a
conventional US machine in 142 subjects.We conclude that,
at present, the BVI is not sufﬁciently accurate to detect AAA
for the purpose of screening. This is consistent with the
conclusion by Abbas et al.,11 where the AortaScan AMI 9700
was compared with CT in 91 subjects (excluding large AAAs
and participants with BMI >35 kg/m2). The authors
concluded that the device lacked adequate measurement
sensitivity (81%) to be used in screening. In contrast, Flu
et al.,10 comparing the BVI 9600 with conventional US in
150 subjects clinically suspected of AAA, concluded that the
BVI 9600 demonstrated a sensitivity (90%) acceptable for
screening. It is difﬁcult to interpret these results, as the
speciﬁc ultrasound measurement variability of the aortic
diameter was not reported in either study. Other studies
comparing CT and US measurements of the abdominal
aorta commonly regard differences of less than 0.5 cm (the
CAD) between the equivalent methods clinically accept-
able.12,13,15,16 In this study, aortic measurements with the
BVI exceeded this speciﬁed limit.The operators were highly skilled which suggests that the
poor performance of the BVI in this study is mainly the
result of its technical shortcomings. Because the BVI de-
mands minimal operator skills, it is doubtful that more
training of the operators can improve the AAA detection
accuracy without substantial technical improvement to the
device. Hartshorne et al.8 suggested the same, and that the
accuracy achieved should be within the CAD before it could
be used in AAA screening.Aneurysm detection
Out of 52 aneurysms detected by conventional US, the BVI
failed to detect nine aneurysms, three due to measurement
inaccuracy, three due to non-visualization of all four seg-
ments of the aorta, and three due to non-visualization of
the distal segments. Reliable identiﬁcation of aneurysm is of
course the goal of screening. The manufacturer of the BVI
stated that the device was designed to simply detect aortic
diameters over 3.0 cm, not to accurately measure the di-
ameters.11 However, inaccurate measurements of the
aneurysmal aortic diameters by the BVI around this point
may have led to its failure to detect a proportion of aneu-
rysms in this study. The aneurysmal aortae were less
accurately measured than the normal ones, evident by a
larger systematic under-measurement bias (0.56 cm) and
measurement variability (1.72 cm). Consequently, the BVI
failed to detect three aneurysms (3.1 cm, 3.56 cm, and
5.74 cm) due to an under-measurement by 0.9 to 3.9 cm
compared to US. Abbas et al.11 have suggested that the BVI
would be more accurate for larger aortae, but this issue
remains controversial in studies comparing different con-
ventional US devices.17,18 Failure of the BVI to detect a
signiﬁcant proportion (33%) of large aneurysms (4 of 12
aneurysms measuring over 5.5 cm) is particularly serious
with signiﬁcant imminent risk of rupture and the lost op-
portunity for immediate repair. The failure to detect 12% of
the smaller AAA while having fewer immediate conse-
quences for the patients still may signiﬁcant clinical
implications.
There are several possible factors accounting for the
poorer performance of the BVI. They include the systematic
bias produced by the difference in measuring the OTO wall
of the vessel with conventional US compared to an ITI wall
technique with the BVI. This would have lead to a system-
atic under-measurement by the BVI and the failure to
detect borderline aneurysms. Automatic adjustment for this
systematic bias is attractive however the size of this effect
was too variable. The effect would be accentuated when
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the inner margin as may occur in aneurysms burdened by
mural thrombi. From this study we considered it to be
preferable for the further development of the BVI or any
other upcoming non-conventional ultrasound devices
designed for AAA screening to follow the more widely used
conventional OTO wall measurement of the aortae. It would
make comparison with current criteria of AAA easier.
However, the measurement technique for the abdominal
aorta remains controversial.19 A recent study by Hartshorne
et al.20 found that the ITI wall method was more repro-
ducible and it is used in at least one screening programme.
The large measurement variability of aneurysmal aortae
with the BVI protocol may be contributed to by the difﬁ-
culties in assessing the aortic diameter in the presence of
vessel tortuosity. Tortuosity makes the detection of the true
cross sectional image difﬁcult. Tortuosity is present in most
ectatic aortae21 and in a signiﬁcant number of aortae going
on to expand into aneurysms.22 The ability to cope with
vessel tortuosity to insure true cross sectional measure-
ment should be a development priority in the technical
improvement of the BVI, as also recommended by
Hartshorne.8
Non-visualization
Non-visualization of the whole aorta or the distal segments
led to failure of the BVI to detect six aneurysms (size range
3.4e6.47 cm). Non-visualization is a well-recognized chal-
lenge in ultrasound scanning of the abdominal aorta,
commonly due to bowel gas and participant obesity.23 This
was no different in this study although it was not quanti-
ﬁed. Real-time scanning and adequate depth of US pene-
tration are both needed to minimize these impediments to
visualization. Unfortunately, the BVI lacks real-time imaging
and has a penetration of only 18 cm. As obesity is associ-
ated with AAA,24 it would be advantageous if real-time
scanning and greater penetration depth could be incorpo-
rated into the BVI. These technical improvements could
particularly minimise the risk of the BVI failing to detect
large aneurysms, four out of 12 large aneurysms (>5.5 cm)
in this study, due to non-visualisation of the aorta, or its
misidentiﬁcation.
Strength of measurement agreement
A reasonable kappa score of AAA detection was achieved,
signifying an agreement between the BVI and conventional
US in regard to detection. In contrast, the sensitivity of
detecting AAA is consistent with the results by Abbas
et al.,11 who concluded that the BVI was not sufﬁciently
sensitive for AAA screening. However, these statistical
measures may be misleading due to AAA being a disease of
relatively low prevalence, a statistical issue reported by
Meehl and Rosen.25
Implications for screening
The conventional US screening cut off for an AAA is 3.0 cm
but the BVI device using an ITI measurement may underestimate this by as much as 2e3 mm and exclude signiﬁcant
numbers of small aneurysms for further surveillance. Hart-
shorne et al.8 suggested that a screening programme using an
automated device like the BVI could select a diameter
threshold below 3.0 cm for participants to have a follow up
conventional US re-evaluation for additional safety. Such an
approach with many additional conventional US scans may
offset the cost-effectiveness of screening programmes. The
minimal operator skill requirement of the BVI eliminates the
need to train staff extensively and bypasses the requirement
of sophisticated ultrasound operator skills. Therefore, this
remains an important potential advantage of the BVI. How-
ever, only with further technical development of the BVI
scanning technology is this strategy with a low-cost auto-
mated device likely to succeed. Another shortcoming of the
BVI currently is its lack of ability to detect iliac artery aneu-
rysms (IAAs). IAAs share similar risk factors with AAAs yet are
underdiagnosed and more lethal when rupturing; thus, there
has been suggestion to screen for isolated and coexisting IAA
during AAA screening.26 However, further studies into the
cost-effectiveness of such approach are required due to the
low incidence of isolated IAA and the unreliable diagnostic
accuracy of ultrasonography in detecting co-existing IAA.27
Limitations of the study include the use of the criteria of
less than 0.5 cm as the acceptable measure of variability.
This is based on inter-observer and intra-observer variability
using conventional US.15,28 However these inter-observer
and intra-observer measures may be different for BVI and
was not analysed in this study. It is expected that such
variability may have contributed to the measurement vari-
ability between the BVI and US system. This does not
detract from the overall reasonable basis for this criteria.
The sonographers in this study had never used the BVI
prior to the study. However, because of their prior experi-
ence in ultrasonography they had a considerable advantage
over inexperienced prospective screeners in the community
for whom the device is designed. We suggest that the
generalisability of the study ﬁndings would apply. Larger
studies in the future are recommended to test the accuracy
of an improved device when used by novices.
CONCLUSION
At present the BVI is not sufﬁciently accurate to detect
AAA for the purpose of screening. The BVI requires sig-
niﬁcant technical development before it can be consid-
ered for screening in the future. However, were it
possible to make these improvements to make the BVI
more accurate while maintaining a low-cost proﬁle by
eliminating the need for extensively trained ultrasound
operators, it could suit a screening model that aims for
low-cost and easy accessibility to residents of rural areas
and other settings where capture rates of current
screening models are low.
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